|
|
|
|
MaRS Innovation selects diabetic wound healing technology as its second commercialization opportunity
See this page online at: http:bioscienceworld.ca/MaRSInnovationselectsdiabeticwoundhealingtechnologyasitssecondcommercializationopportunity Sign up for your free subscription and keep up-to-date.Stay updated on the latest news and...
|
|
|
Registration Deadline Extended for Pharmacy-Based Immunization Delivery Program
MPA is hosting an immunization program July 15 at the Lexington Lansing Hotel.Registration Deadline Extended for Pharmacy-Based Immunization Delivery Program.
|
|
|
Cancer Research donation
A CHEQUE has been presented to the Cancer Research Shop in Montrose.The cheque came from the organisers of the recent House of Dun charity walk and from the Dun Church flower festival. The two fund-raisers made a combined total of 1,661...
|
|
|
Drug & Alcohol Action Team Uses SAS To Tackle Drugs And Save Lives By Improving Joined-Up Delivery
Uses SAS To Tackle Drugs And Save Lives By Improving Joined-Up Delivery02 Jul 2009 The London Borough of Croydon's (DAAT) is using SAS software to achieve better results in its efforts to get more people into drug treatment, reduce drug...
|
|
|
Particle Sciences And Microfluidics Collaborate To Share Formulation And Nanotechnology Expertise For Pharmace
Bethlehem, PA and Newton, MA /PRNewswire/ -- Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTC Bulletin Board: MFLU), and Particle Sciences Inc.(PSI) have formed a strategic alliance to help...
|
|
|
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Application
Location: Bethesda, MD USA Contact Info: Rhonda Williams Phone: 240/221-2908 Fax Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Application.
|
|
|
Important Progress for Diamyd Medical During the Third Quarter
(GLOBE NEWSWIRE) -- Diamyd Medical's President and CEO comments in the company's interim report today on several significant advances during the period, including the positive development of the company's Phase III program.'I'm very...
|
|
|
Novel Drug Delivery Strategies in Neuro-Oncology
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Neurotherapeutics, 07/01/09 Print Save in My Library Free Abstract Bidros DS et al.- Treatment of malignant gliomas represents one of the most formidable...
|
|
|
Scientists kill cancer cells with 'trojan horse'
Australian scientists have developed a 'trojan horse' therapy to combat cancer, using a bacterially-derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills it with chemotherapy drugs.The 'trojan horse'...
|
|
|
Scientists kill cancer cells with 'trojan horse'
Link between Lantus, cancer inconclusive China to screen 10 mln rural women for cervical cancer EU forges partnership for action against cancer Study: Skin cancer drugs smooth wrinkles New blood test increases accuracy in prostrate cancer...
|
|
|
Researchers from AstraZeneca publish findings in drug delivery
'A combination of the corticosteroid budesonide and the long-acting beta 2-adrenergic agonist formoterol is available in the United States in a single hydrofluoroalkane pressurized metered-dose inhaler (pMDI) for treatment of persistent...
|
|
|
New findings from Virginia Commonwealth University describe advances in drug delivery
'For most newly developed spray aerosol inhalers, the generation time is a potentially important variable that can be fully controlled.The objective of this study was to determine the effects of spray aerosol generation time on transport...
|
|
|
New life sciences study findings have been reported by researchers at Carleton University
According to recent research published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery, 'Pressurized metered dose inhalers (pMDIs) are widely used to deliver aerosolized medications to the lungs, most often to relieve...
|
|
|
Research from J.C. Stachowiak and colleagues provide new insights into drug delivery
'Many modern pharmaceutical therapies such as vaccines and macromolecular drugs benefit from transdermal delivery.Conventional transdermal drug delivery via hypodermic needles causes pain, noncompliance, and potential contamination,'...
|
|
|
Research reports from G.J.M. Garcia and co-authors provide new insights into drug delivery
According to recent research published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery, 'Interindividual variability in nasal filtration is significant due to interindividual differences in nasal anatomy and breathing...
|
|
|
MAXY: Conference call regarding Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals @ 16:
Ridgeland, MS, JUL 01, 2009 (EventX/Knobias.com via COMTEX) -- MAXY | Quote | Chart | News | PowerRating -- Maxygen Incorporated (Nasdaq NM : MAXY | Quote | Chart | News | PowerRating) will host a conference call regarding Announces Joint...
|
|
|
Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmace
BETHLEHEM, Pa.and NEWTON, Mass., June 30 /PRNewswire/ -- Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTC Bulletin Board: MFLU), and Particle Sciences Inc. (PSI) have formed a strategic alliance...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc.(TSX:MDS;MDZ), a leading provider of products and services to the global life...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ -- MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
<< MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa >> MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets,...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /CNW/ - MDS Inc.(TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences...
|
|
|
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
<< MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa >> TORONTO, July 1 /CNW/ - MDS Inc.(TSX: MDS - News; NYSE: MDZ - News), a leading provider of products and services to...
|
